Archives

Lipid nanoparticles protect novel RNA-based drugs and deliver them to their sites of action in the body. ISAR Bioscience aims to reduce side effects and to make them more powerful.

ISAR Bioscience aims to teach iPS cells how to fight autoimmune diseases and cancer in an effective and sustained manner.

ISAR Bioscience develops novel antibodies directed against a protein relevant for Alzheimer’s disease. First results are encouraging.

ISAR Bioscience develops new therapies based on ist research projects. Our focus is on three preclinical development projects.